Additionally, hepatocyte-secreted ATX exacerbates NAFLD by inhibiting the peroxisome proliferator-activated receptor-α/fibroblast growth factor-21 axis35. The gene discussed is ENPP2; the disease is metabolic dysfunction-associated steatotic liver disease.